INNOVA CAPTAB
|
INNOVA CAPTAB Last 5 Year Financial Ratios History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Operational & Financial Ratios | |||||
Earnings Per Share (Rs) | 14.15 | 531.54 | 286.86 | 232.23 | 166.01 |
CEPS(Rs) | 16.46 | 14.89 | 8.35 | 7.91 | 6.36 |
DPS(Rs) | - | - | - | - | - |
Book NAV/Share(Rs) | 57.61 | 1,738.38 | 1,206.84 | 919.62 | 687.39 |
Tax Rate(%) | 25.97 | 25.39 | 25.56 | 25.70 | 19.74 |
Margin Ratios | |||||
Core EBITDA Margin(%) | 12.06 | 11.88 | 13.24 | 13.62 | 11.46 |
EBIT Margin(%) | 11.86 | 11.31 | 12.21 | 11.27 | 8.52 |
Pre Tax Margin(%) | 9.74 | 10.60 | 11.26 | 10.03 | 6.96 |
PAT Margin (%) | 7.21 | 7.91 | 8.38 | 7.46 | 5.58 |
Cash Profit Margin (%) | 8.39 | 8.84 | 9.74 | 10.15 | 8.58 |
Performance Ratios | |||||
ROA(%) | 9.99 | 12.58 | 10.48 | 11.57 | 8.72 |
ROE(%) | 28.02 | 36.19 | 27.04 | 28.92 | 24.10 |
ROCE(%) | 24.34 | 30.64 | 28.42 | 26.48 | 19.63 |
Asset Turnover(x) | 1.39 | 1.59 | 1.25 | 1.55 | 1.56 |
Sales/Fixed Asset(x) | 4.46 | 5.17 | 4.10 | 4.07 | 3.98 |
Working Capital/Sales(x) | 5.71 | 9.56 | 7.44 | 7.37 | 11.49 |
Efficiency Ratios | |||||
Fixed Capital/Sales(x) | 0.22 | 0.19 | 0.24 | 0.25 | 0.25 |
Receivable days | 92.58 | 79.30 | 99.91 | 86.65 | 93.14 |
Inventory Days | 47.60 | 49.63 | 69.58 | 50.85 | 39.71 |
Payable days | 100.16 | 88.60 | 122.96 | 108.78 | 101.39 |
Valuation Parameters | |||||
PER(x) | - | - | - | - | - |
PCE(x) | - | - | - | - | - |
Price/Book(x) | - | - | - | - | - |
Yield(%) | - | - | - | - | - |
EV/Net Sales(x) | 0.29 | 0.26 | 0.11 | 0.16 | 0.23 |
EV/Core EBITDA(x) | 2.15 | 2.10 | 0.81 | 1.16 | 2.01 |
EV/EBIT(x) | 2.36 | 2.27 | 0.90 | 1.43 | 2.71 |
EV/CE(x) | 0.35 | 0.34 | 0.11 | 0.24 | 0.36 |
M Cap / Sales | - | - | - | - | - |
Growth Ratio | |||||
Net Sales Growth(%) | 15.72 | 94.94 | 10.00 | 4.92 | - |
Core EBITDA Growth(%) | 24.21 | 77.06 | 6.94 | 27.37 | - |
EBIT Growth(%) | 22.28 | 81.81 | 19.25 | 38.95 | - |
PAT Growth(%) | 6.26 | 85.37 | 23.72 | 40.30 | - |
EPS Growth(%) | -97.34 | 85.30 | 23.53 | 39.89 | - |
Financial Stability Ratios | |||||
Total Debt/Equity(x) | 0.85 | 0.95 | 0.31 | 0.48 | 0.87 |
Current Ratio(x) | 1.59 | 1.27 | 1.26 | 1.39 | 1.26 |
Quick Ratio(x) | 1.17 | 0.86 | 0.83 | 0.89 | 0.93 |
Interest Cover(x) | 5.60 | 16.09 | 12.80 | 9.11 | 5.44 |
Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of INNOVA CAPTAB
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INNOVA CAPTAB | ₹2,641.2 Cr | 1.2% | -0.6% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹366,103.0 Cr | 0.7% | -4.8% | 57.3% | Stock Analytics | |
CIPLA | ₹114,230.0 Cr | 1.9% | -2.4% | 42.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,916.0 Cr | 0.1% | 3% | 12.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,939.2 Cr | 1.3% | 0.5% | 87.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,732.2 Cr | -5.4% | -4.1% | 20% | Stock Analytics |
INNOVA CAPTAB Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INNOVA CAPTAB | 1.2% |
-0.6% |
|
SENSEX | -1.5% |
-2.6% |
17.8% |
You may also like the below Video Courses